InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Aguilar Richard, Directeur Clinique. Director active across 1 company, notably Cano Health, Inc.. Aggregated, 24 reports have been logged. Split: 4 buys · 5 sells. Total volume traded: €2.9m. History available since 25 August 2021. The latest transaction was disclosed on 28 June 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations24 total
150,000 shares@ US$1.2225.8% of flowClass A Common StockSEC:0001209191-23-040344:0
550,000 shares0Class A Common StockSEC:0001209191-23-040036:0
675,940 shares0Class A Common StockSEC:0001209191-23-036903:0
600,000 shares0Class A Common StockSEC:0001209191-23-036903:1
400,000 shares@ US$1.32117.1% of flowClass A Common StockSEC:0001209191-23-036903:2
600,000 shares0Class A Common StockSEC:0001209191-23-036903:3
600,000 shares0Class A Common StockSEC:0001209191-23-036903:4
275,940 shares@ US$1.290711.4% of flowClass A Common StockSEC:0001209191-23-036903:5
100,000 shares@ US$1.37764.4% of flowClass A Common StockSEC:0001209191-23-036903:6
500,000 shares@ US$1.423322.9% of flowClass A Common StockSEC:0001209191-23-036903:7
231,008 sharesClass A Common StockSEC:0000950170-23-026062:0
120,116 sharesClass A Common StockSEC:0000899243-23-010576:0
27,010 shares@ US$1.07520.9% of flowClass A Common StockSEC:0000899243-23-001341:0
171,641 sharesClass A Common StockSEC:0000899243-22-011461:0
200,000 sharesClass A Common StockSEC:0000899243-22-002632:0
200,000 sharesClass A Common StockSEC:0000899243-22-002632
119,407 sharesClass A Common StockSEC:0000899243-21-049383:0
119,407 sharesClass A Common StockSEC:0000899243-21-049383
285,333 sharesClass A Common StockSEC:0000899243-21-037542:0
285,333 sharesClass A Common StockSEC:0000899243-21-037542
1,749 shares@ US$11.931.6% of flowClass A Common StockSEC:0000899243-21-034733:0
Ideal exit: 27 May 2022 (T+270)
1,749 shares@ US$11.930.6% of flowClass A Common StockSEC:0000899243-21-034733
Ideal exit: 27 May 2022 (T+270)
51,393 shares@ US$11.9348.4% of flowClass A Common StockSEC:0000899243-21-034608:0
Ideal exit: 22 May 2022 (T+270)
51,393 shares@ US$11.9318.1% of flowClass A Common StockSEC:0000899243-21-034608
Ideal exit: 22 May 2022 (T+270)
24 of 24 declarations
About Aguilar Richard
Richard Aguilar is the Chief Clinical Officer of Cano Health, Inc. He is responsible for managing the clinical services of the company, ensuring the quality of care provided. His medical expertise is essential in ensuring excellence in healthcare services.
